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Abstract 
 
This study aimed to compare dexmedetomidine and propofol, in terms of haemodynamic parameters, respiratory 
rates and offset times, when used for sedation in patients undergoing elective orthopaedic and surgical procedures 
under regional anaesthesia. This was a prospective, randomised, single-blind study where 88 patients were recruited. 
Patients were randomised into two groups to receive either dexmedetomidine or propofol infusion. Central neuraxial 
blockade (spinal, epidural or combined spinal epidural) was performed. After ensuring an adequate block and stable 
haemodynamic parameters, dexmedetomidine was infused 15 minutes later at 0.4 μg/kg/hr, and propofol, at a target 
concentration of 2.5 μg/ml. Both drugs were titrated to achieve a bispectral index score of 70 before surgery 
commenced. Sedation level was monitored using the bispectral index score and assessed by the Observer Assessment 
of Alertness Scale score. Drug infusion was adjusted to maintain bispectral index scores ranging between 70-80 
during surgery. Both groups showed reductions in mean arterial pressure and heart rate from baseline readings 
throughout the infusion time. However there was no significant reduction in the first 15 minutes from baseline (p > 
0.05). Haemodynamic parameters and respiratory rate between both groups were not significantly different (p > 
0.05). No patient demonstrated significant respiratory depression or SpO2 ≤ 95%. Offset times were also not 
significantly different between both groups (p = 0.594). There were no significant differences in haemodynamic 
parameters, respiratory rates and offset times between dexmedetomidine and propofol used for sedation in patients 
undergoing elective orthopaedic and surgical procedures under regional anaesthesia. 
 
Keywords: Dexmedetomidine, propofol, sedation, regional anaesthesia, bispectral index 
 
Correspondence: 
 
Dr. Nadia Md Nor, Department of Anaesthesiology & Intensive Care, Universiti Kebangsaan Malaysia Medical Centre, 56000 
Cheras, Kuala Lumpur, Malaysia. Tel no: +60391455621 Fax: +60391456585 Email: nadiamn72@yahoo.com
  
Date of submission: 12 June, 2012           Date of acceptance: 25 July, 2012 
 
Introduction 
 
Sedation is given during regional anaesthesia to 
enhance patient comfort. Patients may feel 
uncomfortable and become restless especially if they 
need to remain immobile during a procedure. Sedation 
has been shown to increase patient satisfaction and 
acceptance of regional anaesthesia (1). The selection 
of sedative agents depends on physician preference 
and the patient’s premorbid status. Ideally, the sedated 
patient should be able to respond to physical and 
verbal stimuli, and also maintain their airway 
independently.   A wide variety of centrally-acting 
drugs such as propofol, midazolam, clonidine and 
dexmedetomidine have been used to provide sedation 
and anxiolysis (1,2).  
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Propofol (2,6-diisopropylphenol) is an intravenous 
sedative-hypnotic agent used for induction and 
maintenance of general anaesthesia, as well as for 
sedation in patients undergoing surgery under regional 
anaesthesia. It acts by facilitating the inhibitory 
neurotransmission mediated by gamma amino butyric 
acid (1). The advantages of propofol are its rapid onset 
of action, easy titration, rapid emergence as well as 
antiemetic property (3-6). Propofol for intraoperative 
sedation can be delivered via target control infusion 
(TCI) with target plasma concentrations ranging 
between 1.0 - 3.0 μg/ml (2,4). 
 
Dexmedetomidine is a selective α-2 receptor agonist, 
with potent sedative, anxiolytic and analgesic 
properties. Unlike propofol, it acts primarily on the 
postsynaptic α-2 receptor causing sedation and 
sympatholytic effects (1). Patients receiving 
dexmedetomidine at infusion rates ranging between 
0.3 - 0.7 μg/kg/hour are effectively sedated, yet easily 
aroused with minimal respiratory depression (1,2).  Its 
short half-life enables patients to have a rapid recovery 
with minimal hangover effect (2,7).  It was licensed 
for use in the intensive care unit as a sedative for a 
maximum of 24 hours only (1,2,8).  However, in 2008, 
the U.S Food and Drug Administration (FDA) 
approved the use of dexmedetomidine in non-
intubated patients requiring sedation prior to and/or 
during surgical and other procedures. Studies have 
reported the use of dexmedetomidine for sedation in 
non-intubated patients during regional anaesthesia, 
radiological imaging and other procedures (7,9,10). 
 
Both drugs provide effective sedation, but have 
slightly different cardiorespiratory effects, especially 
if a rapid loading dose was given (7-9). Propofol may 
be associated with cardiovascular depression, 
resulting in hypotension due to a reduction in 
systemic vascular resistance and cardiac contractility, 
and respiratory depression leading to apnoea (2,9,10). 
Although dexmedetomidine causes cardiovascular 
depression due to decreases in sympathetic outflow, 
it has only minimal effects on respiration (2,9). 
However, studies have shown that there were no 
significant haemodynamic effects when 
dexmedetomidine was used for sedation without a 
loading dose (11,12). 
 
The aim of this study was to compare 
dexmedetomidine versus propofol, in terms of 
haemodynamic parameters, respiratory rates and offset 
times, when used for sedation in patients undergoing 
elective orthopaedic and surgical procedures under 
regional anaesthesia. 
 
Materials and Methods 
 
Subjects 
 
This was a prospective, randomised, single-blind 
study. After obtaining institutional ethics committee 
approval and informed consent, patients of American 
Society of Anesthesiologists (ASA) physical status I or 
II, aged 18-70 years, planned for orthopaedic or 
surgical procedures requiring central neuraxial 
blockade were recruited into the study. Patients with 
allergies to the study drugs, potential airway 
difficulties, body mass index (BMI) ≥ 35 kg/m 2, on 
sedative medications and with conditions associated 
with low cardiac output, bradyarrhythmias, conduction 
defects and renal impairment were excluded from the 
study.  
 
Methodology 
 
Patients were fasted from midnight and given oral 
midazolam 3.75 mg the night before surgery. In the 
operating theatre, the patients were randomised into 
two groups using computerised generated randomised 
numbers. Group A patients received dexmedetomidine 
(PrecedexTM, Abbott Laboratories) infusion, and 
Group B patients received propofol (DiprivanTM, Astra 
Zeneca) infusion.  An 18G cannula was inserted and 
standard anaesthetic monitoring (electrocardiograph, 
pulse oximeter and non invasive blood pressure 
monitor) was applied. The bispectral index (BISTM) 
monitor (model A-2000, Aspect Medical Systems Inc.) 
was also used to monitor the level of sedation. The 
BIS is an index of depth of sedation, where completely 
awake patients scored 90 to 100; consciously sedated 
patients, 70 to 89; patients under general anesthesia, 
50 to 69; and deeply sedated and comatosed patients, 0 
to 50. The Observer Assessment of Alertness Scale 
(OAAS) was used together with the BIS score to 
monitor the depth of sedation, where the scores and 
corresponding responses were as follows: 6-Agitated; 5-
Responds readily to name spoken in normal tone (alert); 
4-Lethargic response to name spoken in normal tone; 3 - 
Responds only after name is called loudly and/or 
repeatedly; 2-Responds only after mild prodding or 
shaking ; 1-Does not respond to mild prodding or 
shaking ; 0-Does not respond to deep stimulus. 
 
Haemodynamic parameters prior to the administration 
of regional anaesthesia were recorded. Regional 
anaesthesia (spinal, epidural or combined spinal 
epidural anaesthesia) was performed under full aseptic 
technique following standard protocols. Once an 
adequate level of anaesthesia was established, 
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supplemental oxygen at 5 L/min was given to all 
patients via face mask. The patients were monitored 
for blood pressure changes secondary to central 
neuraxial blockade. A reduction of ≥ 20% from the 
initial mean arterial pressure (MAP) was treated 
according to the study protocol. Infusion of the study 
drugs was started 15 minutes after, when the MAP was 
within 20% of initial readings. The drugs were infused 
using the Terufusion Syringe Pump TE-331 and 
baseline parameters were recorded before commencing 
drug infusion. In Group A, the infusion was started at 
an initial rate of 0.4 μg/kg/hour and increased in 
increments of 0.1 μg/kg/hour every five minutes, up to 
a maximum rate of 0.7 μg/kg/hour, to reach a target 
BIS score of 70. In Group B, TCI with a GrasebyTM 
3400 Syringe Pump was used, starting at a target 
concentration of 2.5 μg/ml and increased in increments 
of 0.2 μg/ml every three minutes, up to a maximum of 
3 μg/ml, to reach a target BIS score of 70.  Surgery 
was then allowed to proceed and the infusion rate or 
target concentration was adjusted as necessary to 
maintain a BIS score of between 70- 80 throughout the  
 
Table 1: Demographic data, ASA class and duration of 
surgery. Values are expressed in mean ± SD and numbers 
(percentage) where appropriate 
 
 Group A 
(n=43) 
Group B 
(n=42) 
Age (years)  57.5 ± 14.9 57.4 ± 15.2 
Weight (kg)  68.0 ± 5.1 68.1 ± 4.7 
Gender  
      Male  
      Female  
28 (65.1%) 
15 (34.9%) 
20 (47.6%) 
22 (52.4%) 
Race  
      Malay  
      Chinese  
      Indian  
      Others  
16 (37.2%) 
17 (39.5%) 
6 (14.0%) 
4 (9.3%) 
22 (52.4%) 
11 (26.2%) 
6 (14.3%) 
3 (7.1%) 
ASA   
       І  
      ІІ  
 
19 (44.2%) 
24 (55.8%) 
 
20 (47.6%) 
22 (52.4%) 
Duration of surgery 
(minutes)  85.6 ± 13.1 86.9 ± 12.8 
 
Table 2: Types of surgery. Values are expressed in numbers. 
 
 Group A 
( n=43 ) 
Group B 
( n=42 ) 
Surgical  
     Inguinal hernia repair 
     Fistula in ano repair 
     Others  
Orthopaedic  
     Arthroplasty  
     Femur instrumentations 
     Others 
 
14 
4 
4 
 
10 
7 
4 
 
12 
2 
4 
 
10 
9 
5 
duration of surgery. All parameters were documented 
at 15-minute intervals till completion of surgery. The 
BIS score was recorded before OAAS assessment to 
ensure that the former was not affected by the verbal 
and tactile stimulation used to assess OAAS. The 
infusion was stopped at the end of skin closure. Offset 
time was defined as the interval between the cessation 
of infusion and the return of BIS score ≥ 90.  
 
Any adverse events which occurred during the study 
was documented and treated accordingly. These 
included bradycardia (change of heart rate (HR) <20% 
baseline); tachycardia (change of HR > 20% baseline); 
hypotension (change MAP <20% of baseline); 
hypertension (change MAP >20% of baseline) and 
respiratory depression (respiratory rate (RR) ≤ 8 
breaths/min). In the event of bradycardia, the drug 
infusion was reduced. Intravenous atropine 0.4 mg was 
administered depending on the severity of the 
bradycardia. If the patient became hypotensive, the 
drug infusion was reduced and fluid resuscitation with 
crystalloids (250-500 ml of Ringer`s lactate solution) 
and/or bolus doses of ephedrine 6 mg or phenylephrine 
50µg was given accordingly. If the patient’s 
respiration was depressed, the drug infusion rate was 
reduced accordingly. However, if the SpO2 
subsequently dropped to ≤ 95%, the infusion was 
stopped. These patients were supported with 
appropriate airway devices, and assisted ventilation 
initiated. Those who required conversion to general 
anaesthesia were excluded from analysis. 
 
Statistical analysis 
 
This study was powered to detect a 15% difference in 
intraoperative MAP or HR from baseline, with an 
alpha value of 0.05 and beta value of 0.2. Using the 
power and sample size software PS by Dupont, a 
sample size of 40 patients per arm was obtained with a 
power of study of 0.8. Allowing for a dropout rate of 
10%, a total of 88 patients were required for this study.   
 
 
For statistical evaluation, all data analysis was done 
using the SPSS version 17.0 software. Student`s t-test 
was used for analyzing age, weight, MAP, HR, RR, 
duration of surgery and offset times, while Chi-Square 
test was used to analyze gender, race, ASA class and 
types of surgery between the two groups. A p-value of 
less than 0.05 was considered statistically significant. 
 
Results  
 
Of the 88 patients enrolled in the study, 85 were 
included in the final analysis, with 43 in Group A and 
42 in Group B. One patient was excluded due to severe 
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bleeding affecting haemodynamic parameters and two 
others due to inadequate block intraoperatively, 
requiring conversion to general anaesthesia. There 
were no statistically significant differences (p > 0.05) 
in terms of demographic data (age, weight, gender and 
race), ASA class and the duration of surgery between 
the two groups as shown in Table 1. The types of 
surgery between both groups were not significantly 
different; surgical procedures (Group A; 51.2% versus 
Group B; 42.9%), and orthopaedic procedures (Group 
A; 48.8% versus Group B; 57.1%); (Chi-Square 
analysis; p=0.443). This is shown in Table 2.  
 
Figure 1 shows that there was no significant difference 
(p > 0.05), in mean MAP between the two groups at 
every 15 minute interval. There was no significant 
difference (p > 0.05), in mean HR between the two 
groups at every 15 minute interval, as shown in Figure 
2. Figure 3 shows that there was no significant 
difference (p > 0.05), in mean RR between the two 
groups at every 15 minute interval. None of the 
patients developed respiratory depression or SpO2 ≤ 
95. The mean offset times was not statistically 
different (p = 0.594), between Group A and Group B, 
7.0 ± 1.3 minutes and 6.8 ± 1.4 minutes, respectively. 
 
Discussion 
 
A loading dose of 1 μg/kg of dexmedetomidine has 
been associated with a biphasic response, i.e transient 
hypertension followed by severe hypotension (2,7,9), 
though the latter is more common (13-17).  A loading 
dose of propofol prior to starting an infusion has also 
been associated with significant hypotension and 
bradycardia (1,2).  In this study, the loading dose was 
omitted in both groups, and in the first 15 minutes, we 
observed no significant decrease in MAP and heart 
rate from baseline. In studies where a rapid loading 
dose was given at the beginning of drug infusion, a 
significant decrease in the MAP and heart rate was 
documented in the first 10 minutes with the use of 
either dexmedetomidine or propofol for sedation (7,9). 
In contrast, studies which omitted the loading dose 
showed insignificant changes in the heart rate from 
baseline (11,12).  
 
This study found that patients sedated with propofol 
had a lower MAP throughout the study, compared to 
patients sedated with dexmedetomidine. However, this 
difference was statistically insignificant and in keeping 
with previous studies which showed similar findings 
(8,10,13).  These studies also reported that in both 
groups, the mean heart rate was also reduced from 
baseline readings throughout the infusion time (10,13). 
However, the reduction was not statistically significant 
and was most probably due to the sympatholytic effect 
of dexmedetomidine, and partly due to the direct 
myocardial depressant effect of propofol. 
 
 
 
 
  
 
difference (p = 0.594). 
 
 
 
 
 
 
 
 
 
 
Figure 1: Mean values of mean arterial pressure (MAP) at 
15 minute intervals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Mean heart rate (HR) at 15 minute intervals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Mean respiratory rate (RR) at 15 minute intervals. 
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Anecdotal reports described incidences of respiratory 
depression during infusion of propofol for sedation 
(1,2). However, in this study, patients who received 
propofol did not show any significant respiratory 
depression requiring adjustment of rate of infusion, or 
SpO2 ≤ 95% requiring assisted ventilation. This 
preservation of respiratory function may be related to 
the study design which did not include a loading dose 
of propofol at the onset of infusion. The difference in 
the mean respiratory rate between the 
dexmedetomidine and propofol groups in this study 
was not statistically significant, and this was in 
agreement with findings in previous studies (9,10,15).  
Both drugs showed no respiratory depression, possibly 
due to the fact that the drugs were carefully titrated to 
the targeted sedation score, and immediate dose 
adjustments were done when needed.  
 
In this study, the offset time was slightly prolonged, 
though not statistically significant, with 
dexmedetomidine compared to propofol. This finding 
was similar to previous studies (8,9).  This may be 
explained by the 2 hour elimination half life (t1/2 β) of 
dexmedetomidine compared to the elimination half life 
of propofol which ranges between 21 to 69 minutes. 
However, in another study, a statistically significant 
prolonged offset time of sedation with 
dexmedetomidine was found when compared to 
propofol (10). The cause of this discrepancy was not 
explained and further studies may be needed to 
evaluate this issue. 
 
BIS was used to maintain equivalent sedative levels in 
the two groups. It has been shown to be a simple tool 
in assessing the level of consciousness during the 
period of sedation (2,12).  However, some studies 
showed variable BIS scores when it was used alone to 
correlate the depth of anaesthesia (1,6). To optimize 
accuracy in maintaining the depth of sedation, the 
OAAS was used together with the BIS score for 
monitoring the depth of sedation during regional 
anaesthesia. Previous studies have shown good 
correlation between the two scores (2,15).  
 
There were a number of limitations to this study. 
Firstly, there was no control group as it would be 
unethical to deprive those patients in whom sedation 
was warranted. Secondly, the variability of central 
neuraxial blockade used (spinal, epidural or combined 
spinal epidural) may have influenced the 
haemodynamic profiles exhibited by the patients, thus 
it would have been better to standardize the use of one 
regional technique rather than employing multiple 
regional techniques. Variability in surgical procedures 
in this study may have also influenced changes in 
haemodynamic parameters (due to differences in blood 
and third space losses) during drug infusion, thus 
affecting the type of intervention that was required (in 
terms of amount of fluid resuscitation and 
vasopressors used). Haemodynamic parameters were 
also measured at 15 minute intervals within which 
significant changes may have occurred and missed. 
 
Dexmedetomidine or propofol when used at 
appropriate infusion rates alleviate the fear and anxiety 
faced by patients undergoing surgical procedures 
under regional anaesthesia. Additionally, with 
dexmedetomidine, presynaptic and postsynaptic 
activation of the α2-adrenoceptors in the central 
nervous system terminate the propagation of pain 
signals, and inhibit sympathetic activity respectively. 
These combined effects produce analgesia, sedation, 
and anxiolysis, thus avoiding the potential side effects 
when multiagent therapies are used (18). 
Dexmedetomidine is also associated with a lower rate 
of shivering (19) which is an added benefit as patients 
given central neuraxial blocks may have intraoperative 
shivering secondary to loss of heat from peripheral 
vasodilatation. 
 
We concluded that there were no significant 
differences in terms of haemodynamic parameters, 
respiratory rates and offset times between 
dexmedetomidine and propofol when used for 
conscious sedation, in patients undergoing elective 
orthopaedic and surgical procedures under regional 
anaesthesia. 
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